Procaps Group S.A. (NASDAQ:PROC – Get Free Report)’s share price was down 0.6% on Thursday . The stock traded as low as $1.69 and last traded at $1.80. Approximately 28,512 shares were traded during mid-day trading, an increase of 135% from the average daily volume of 12,132 shares. The stock had previously closed at $1.81.
Procaps Group Trading Down 0.6 %
The firm has a market cap of $203.08 million, a price-to-earnings ratio of 3.46 and a beta of 0.15. The stock’s fifty day moving average price is $2.11 and its 200-day moving average price is $2.54.
Procaps Group Company Profile
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
Featured Articles
- Five stocks we like better than Procaps Group
- What Are Dividend Contenders? Investing in Dividend Contenders
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- How to Invest in the Best Canadian Stocks
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
